 |
[Alpha Biz=(Chicago) Reporter Kim Jisun] Seo Jung-jin, chairman of Celltrion, also predicted that he will consider listing "Celltrion Holdings," a holding company, after the merger with Celltrion, Celltrion Healthcare and Celltrion Pharmaceutical, which are currently being pursued step by step.
Earlier, Celltrion has released a blueprint to merge Celltrion and Celltrion Healthcare by the end of this year and Celltrion Pharmaceutical within the next six months. Chairman Seo has a 97% stake in Celltrion Holdings.
According to Celltrion on the 25th, Chairman Seo made the remarks during an online meeting with Celltrion Group investors on the 24th.
"We will push for a second-phase merger with Celltrion Pharmaceutical, and after that, we will consider listing Celltrion Holdings," he said. "If we have surplus funds, we will further expand our stake. We will not seek profits from the sale of stocks by selling Holdings or I or our shares."
Celltrion Group's governance structure is structured by Celltrion Holdings, a holding company, with three companies: Celltrion, Celltrion Healthcare and Celltrion Pharmaceutical. In particular, Chairman Seo is a major shareholder with a 97.19% stake in Celltrion Holdings. In addition, Seo will travel around Japan, Singapore, Hong Kong, the United States and Europe to support existing investors related to the merger and attract new investment.
Integrated Celltrion expects sales to reach 3.5 trillion won next year.
Alphabiz Reporter Kim Jisun(stockmk2020@alphabiz.co.kr)
